Date: October 8, 2026  |  Time: 4:45 to 8:00 pm
Location: In-Person at the Eisenhower Conference Center - Center for Nursing Excellence, 290 Mt Pleasant Avenue, Livingston, NJ

Program Moderator
Theresa M. Redling, DO, FACP, Chief, Geriatric Health and Disease Management and Medical Director, Maida Geriatric Institute, Cooperman Barnabas Medical Center; Assistant Clinical Professor of Medicine, Rutgers New Jersey Medical School

Program Agenda

4:45 pm | Registration and Refreshments/Light Meal

5:00 pm | Welcome
Kristin Fless, MD, Chairperson, Department of Medicine Cooperman Barnabas Medical Center

5:00 | Introduction
Theresa M. Redling, DO, FACP, Chief, Geriatric Health and Disease Management and Medical Director, Maida Geriatric Institute, Cooperman Barnabas Medical Center; Assistant Clinical Professor of Medicine, Rutgers New Jersey Medical School

5:15 pm | Fundamentals of Geriatric Nutrition and Supplements for Health
Mikhail Kogan, MD

6:00 pm | Diabetic Nutrition
Jennifer Meyers, MS, RDN, BC-ADM, CDCES

6:45 pm | Break

7:00 pm | Use of GLP-1 Receptor agonists in Diabetes and Metabolic Syndrome
Chirag Boradia, DO, Endocrinologist

7:45 pm | Questions & Answers

8:00 pm | Adjourn

For questions, reach out to Helene DeCapua at Helene.DeCapua@rwjbh.org

Target Audience: Physicians, Nurses, Case Managers, APNs, Social Workers, Psychiatrists, Psychologists, Skilled Nursing Facilities, and Allied Health Professionals

Learning Outcome: Enable clinicians to synthesize evidence based nutritional strategies and modern pharmacotherapy including GLP-1 receptor agonists to improve clinical outcomes in complex geriatric and metabolic patient populations.

Learning Objectives:

• Assess age related nutritional vulnerabilities in older adults and select appropriate evidence-based supplementation.
• Formulate personalized medical nutrition therapy protocols to optimize glycemic control and long-term metabolic health in patients with diabetes.
• Appraise the clinical indications, physiological mechanisms, and safety parameters of GLP-1 receptor agonists for managing diabetes and metabolic syndrome.

Continuing Medical Education Credit

AMA Credit Designation Statement: Cooperman Barnabas Medical Center designates this virtual education activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy: It is the policy of Cooperman Barnabas Medical Center, Office of Continuing Medical Education to ensure balance, independence, transparency, objectivity and scientific rigor in all CME sponsored educational activities. All participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict(s) of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devises. This information will be available as part of the activity material.

Faculty Disclosures: No relevant financial relationship(s)

Acknowledgement of Commercial Support: No commercial support was provided for this continuing educational activity.